Report #2871127

Received Nov 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: KY
Recovered: Unknown
Vaccinated: Oct 24, 2025
Onset: Oct 24, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	3SB3G	—

Symptoms (1)

Expired product administered

Symptom narrative

Expire dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 3SB3G, expiry date 16-OCT-2025) for prophylaxis. On 24-OCT-2025, the patient received Arexvy. On 24-OCT-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Expire dose). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 24-OCT-2025 The pharmacist reported they administer an expire dose of Arexvy vaccine. The vaccine administration facility was the same as primary reporter.